| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| MYC |
P493-6 (B-cell lymphoma) |
0.2 µg/mL Tetracycline (Myc transgene repressed) for 72h and then released in fresh medium without Tetracycline for 1h |
Permissive
Robust
|
Homo sapiens |
GSE51004
...
|
MA0059.1
...
|
| MYC |
P493-6 (B-cell lymphoma) |
0.2 µg/mL Tetracycline (Myc transgene repressed) for 72h and then released in fresh medium without Tetracycline for 24h |
Permissive
Robust
|
Homo sapiens |
GSE51004
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
serum starved (0% FBS for 48h), then serum stimulated (10% FBS for 1h) |
Permissive
Robust
|
Mus musculus |
GSE51004
...
|
MA0059.1
...
|
| MYC |
3T9 fibroblasts |
serum starved (0% FBS for 48h), then serum stimulated (10% FBS for 2h) |
Permissive
Robust
|
Mus musculus |
GSE51004
...
|
MA0059.1
...
|
| MYC |
liver tumor |
LAP-tta-Arid1afl/fl;Alb-cre;TRE-MYC |
Permissive
Robust
|
Mus musculus |
GSE102607
...
|
MA0059.1
...
|
| MYC |
liver tumor |
LAP-tta-Arid1afl/+;Alb-cre;TRE-MYC |
Permissive
Robust
|
Mus musculus |
GSE102607
...
|
MA0059.1
...
|
| MYC |
liver tumor |
LAP-tta-Arid1aflfl;TRE-MYC (WT) |
Permissive
Robust
|
Mus musculus |
GSE102607
...
|
MA0059.1
...
|
| MYC |
NCI-H2171 (small cell lung carcinoma) |
Treatment: Treatment withKL-1 or KL-2 inhibitors was administrated only once; Genotype: mutation by amplification of MYC; |
Permissive
Robust
|
Homo sapiens |
GSE112608
...
|
MA0059.1
...
|
| MYC |
HEK293T (embryonic kidney) |
Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected with control vector; |
Permissive
Robust
|
Homo sapiens |
GSE112608
...
|
MA0059.1
...
|
| MYC |
HEK293T (embryonic kidney) |
Treatment: withKL-1 or KL-2 inhibitors was administrated only once; Genotype: cells lentiviral infected shRNA targeting MYC; |
Permissive
Robust
|
Homo sapiens |
GSE112608
...
|
MA0059.1
...
|
Showing 10 records in page 424
from 772 pages